| Offering Information |
| Expected Date | WITHDRAWN |
| Proposed Exchange/Ticker |
NYSE: SGLX |
| Security Type |
Common Stock |
| Lead Underwriter |
UBS Investment Bank Piper Jaffray Inc |
| Days In Registration |
91 |
| Date Filed |
28-Sep-2012 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2012) |
| Industry |
Healthcare |
| Business Description |
Singulex Inc, located in Alameda, California, provides medical services. The company provide instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. It focus on advancing industry-leading sample analysis and custom assay development services. It was founded in 1997. |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
15.34M |
| Contact |
- |
| Number of Employees |
- |
|
| Original Filing Information |
| US |
| Shares Filed |
- |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
- |
| File Amount |
- |
| File Price Range |
- - - |
| File Mid Price |
- |
|
